De-Iron: a phase 2 trial of the activity and safety of Deferasirox administered at early iron loading in patients with transfusion-dependent myelodysplastic syndromes - Killick, S; Jackson, A; Coulthard, HC; Yap, C; Das-Gupta, E; Pennell, DJ; Porter, J; Bowen, D; Culligan, D (BRITISH JOURNAL OF HAEMATOLOGY, 2020)